1. Home
  2. CNTA vs EPAC Comparison

CNTA vs EPAC Comparison

Compare CNTA & EPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • EPAC
  • Stock Information
  • Founded
  • CNTA 2020
  • EPAC 1910
  • Country
  • CNTA United Kingdom
  • EPAC United States
  • Employees
  • CNTA N/A
  • EPAC N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • EPAC Industrial Machinery/Components
  • Sector
  • CNTA Health Care
  • EPAC Technology
  • Exchange
  • CNTA Nasdaq
  • EPAC Nasdaq
  • Market Cap
  • CNTA 2.2B
  • EPAC 2.3B
  • IPO Year
  • CNTA 2021
  • EPAC N/A
  • Fundamental
  • Price
  • CNTA $16.63
  • EPAC $45.43
  • Analyst Decision
  • CNTA Strong Buy
  • EPAC
  • Analyst Count
  • CNTA 8
  • EPAC 0
  • Target Price
  • CNTA $23.00
  • EPAC N/A
  • AVG Volume (30 Days)
  • CNTA 964.8K
  • EPAC 266.4K
  • Earning Date
  • CNTA 03-27-2025
  • EPAC 03-19-2025
  • Dividend Yield
  • CNTA N/A
  • EPAC 0.09%
  • EPS Growth
  • CNTA N/A
  • EPAC 63.65
  • EPS
  • CNTA N/A
  • EPAC 1.65
  • Revenue
  • CNTA $6,853,000.00
  • EPAC $592,736,000.00
  • Revenue This Year
  • CNTA N/A
  • EPAC $7.71
  • Revenue Next Year
  • CNTA N/A
  • EPAC $7.87
  • P/E Ratio
  • CNTA N/A
  • EPAC $29.75
  • Revenue Growth
  • CNTA N/A
  • EPAC N/A
  • 52 Week Low
  • CNTA $7.75
  • EPAC $32.07
  • 52 Week High
  • CNTA $19.09
  • EPAC $51.91
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 48.19
  • EPAC 51.45
  • Support Level
  • CNTA $15.50
  • EPAC $45.19
  • Resistance Level
  • CNTA $18.55
  • EPAC $47.47
  • Average True Range (ATR)
  • CNTA 1.25
  • EPAC 0.91
  • MACD
  • CNTA -0.12
  • EPAC 0.08
  • Stochastic Oscillator
  • CNTA 31.57
  • EPAC 35.37

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

About EPAC Enerpac Tool Group Corp.

Enerpac Tool Group Corp provides high-precision tools, controlled-force products, and solutions for precise heavy lifting. The company has one reportable segment, the Industrial Tools & Services (IT&S) Segment. The IT&S segment is engaged in the design, manufacture, and distribution of branded hydraulic and mechanical tools and in providing services and tool rental to the refinery/petrochemical; general industrial; industrial maintenance, repair, and operations (MRO); machining & manufacturing; power generation; infrastructure; mining; and other markets. Geographically, the company has operations in Algeria, Australia, Brazil, France, Germany, Kazakhstan, India, Italy, Japan, Norway, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Spain, and the United Arab Emirates.

Share on Social Networks: